Δευτέρα 11 Δεκεμβρίου 2017

Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer

Pancreatic cancer is a lethal disease in part because of its potential for aggressive invasion and metastasis. Lipoxin A4 (LXA4) is one of the metabolites that is derived from arachidonic acid and that is cata...

from Cancer via ola Kala on Inoreader http://ift.tt/2ygo4E2
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου